Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Private Formulations is a contract development and manufacturing organization (CDMO) that specializes in the production of vitamins, minerals, supplements, and over-the-counter (OTC) medications. The company offers a comprehensive suite of services including product formulation, manufacturing, and packaging across multiple dosage forms such as tablets and capsules. Originally an independent entity based in New Jersey, it was acquired by Bettera Brands in 2017 and later became part of Catalent following Catalent's acquisition of Bettera in 2021. The company is recognized for its high-quality manufacturing standards and its ability to support large-scale production for global consumer health brands. Its facilities are FDA-registered and adhere to current Good Manufacturing Practices (cGMP) to ensure product safety and efficacy. Today, the Edison-based operations serve as a key site within Catalent's consumer health division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Private Formulations.